{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"011-151-540-155-482","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"011-151-540-155-482","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":10731,"type":"PATENT","title":"The University of North Carolina at Chapel Hill - Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":8887,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8232,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners separately:\"uni* north caro*\". Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 1000
Search Applicants and Owners separately:\"uni* north caro*\". Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 1000
(a) providing a heterozygous cellular library comprising a plurality of isolated parent cells, wherein:\n\n(i) the plurality of isolated parent cells comprise a plurality of different genetic modifications; and\n(ii) each of the plurality of isolated parent cells comprises a marked chromosome pair comprising a first selectable marker at a first position distal to a first site-specific recombination site on a first chromosome of the marked chromosome pair, and a second selectable marker at a second position distal to a second site-specific recombination site of a second homologous chromosome of the marked chromosome pair, wherein the first and second selectable markers are both selected from the group consisting of dominant, negative selectable markers and recessive, positive selectable markers, thereby permitting recovery of the marked chromosome pair; and\n(iii) the plurality of isolated parent cells comprises a randomly mutagenized population of isolated cells;\n
(b) providing a site-specific recombinase to the plurality of isolated parent cells, thereby inducing site-specific mitotic recombination in the plurality of isolated parent cells;\n
(c) culturing the plurality of parent cells, whereby a population of daughter cells is produced;\n
(d) replica plating the population of daughter cells;\n
(e) selecting one replica of the population of daughter cells for each of the first and the second selectable markers; and\n
(f) isolating at least one daughter cell comprising a homozygosed first chromosome of the marked chromosome pair and at least one daughter cell comprising a homozygosed second homologous chromosome of the marked chromosome pair, whereby a homozygous cellular library is prepared."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein each cell of a randomly mutagenized population of isolated cells comprises one or more heterozygous genetic modifications."],"number":2,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 2, wherein the one or more heterozygous genetic modifications comprise genetic modifications produced by a method selected from the group consisting of chemical mutagenesis, ultraviolet radiation, X-ray radiation, exposure to inhibitors of DNA repair, and combinations thereof."],"number":3,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the plurality of isolated parent cells comprises cells selected from the group consisting of stem cells, precursor cells, and differentiated cells."],"number":4,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 4, wherein the stem cells comprise embryonic stem cells."],"number":5,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the plurality of isolated parent cells comprise animal cells."],"number":6,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 6, wherein the animal cells comprise human cells."],"number":7,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the plurality of isolated parent cells comprise plant cells."],"number":8,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the first and second site-specific recombination sites each comprises a centromeric position."],"number":9,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein\n
(a) the first selectable marker is a dominant, positive selectable marker;\n
(b) the second selectable marker is a dominant, positive selectable marker; or\n
(c) the first and second selectable markers are dominant, positive selective markers."],"number":10,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the first and second site-specific recombination sites each comprises a lox site."],"number":11,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the first and second site-specific recombination sites each comprises an FRT site."],"number":12,"annotation":false,"claim":true,"title":false},{"lines":["The method of 1, wherein the first and second site-specific recombination sites each comprises an att site."],"number":13,"annotation":false,"claim":true,"title":false},{"lines":["The method of 1, wherein the first and second site-specific recombination sites can recombine to produce a stable first recombination event."],"number":14,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 14, wherein the first site-specific recombination site comprises a lox66 site, and wherein the second site-specific recombination site comprises a lox71 site."],"number":15,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 14, wherein the first site-specific recombination site comprises an attB site, and wherein the second site-specific recombination site comprises an attP site."],"number":16,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the inducing site-specific recombination comprises contacting the cells with a site-specific recombinase."],"number":17,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 17, wherein the site-specific recombinase is selected from the group consisting of a Cre recombinase, a FLP recombinase, and an Int recombinase."],"number":18,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 17, wherein the site-specific recombinase comprises a cell-permeable recombinase."],"number":19,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 19, wherein the cell-permeable recombinase comprises a cell-permeable Cre recombinase."],"number":20,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the culturing further comprises inducing the daughter cells to differentiate."],"number":21,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}